NEW YORK (GenomeWeb News) – Strategic Diagnostics said today that it has signed an agreement to supply reagents to “a large manufacturer of in vitro diagnostics.”
 
The term of the agreement is five years, and the company said that it expects initial revenues of around $1 million per year, which are anticipated to “more than double” over the term of the agreement.
 
Strategic Diagnostics said it will begin shipping the reagents to the undisclosed client in the fourth quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.